Table of contents
Volume 95, Issue S1
Published online 12 December 2006 (S1-S19)
Top of page
Top of page
Introduction
Histone deacetylase inhibition: a novel approach to cancer treatment FREE
B D Cheson
Br J Cancer 95: S1-S1; doi:10.1038/sj.bjc.6603462
Articles
Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor FREE
V M Richon
Br J Cancer 95: S2-S6; doi:10.1038/sj.bjc.6603463
Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma FREE
O A O'Connor
Br J Cancer 95: S7-S12; doi:10.1038/sj.bjc.6603464
Clinical and laboratory experience of vorinostat (suberoylanilide hydroxamic acid) in the treatment of cutaneous T-cell lymphoma FREE
M Duvic and C Zhang
Br J Cancer 95: S13-S19; doi:10.1038/sj.bjc.6603465
The published online date indicates the date that the issue is published online and is the first official publication date of the issue.
